COMMENTING ON THE CONCENTRATION OF AFP, AFP-L3, PIVKA II AND CHARACTERISTICS OF ABDOMINAL ULTRASOUND IN HEPATITIS B PATIENTS AT BACH MAI HOSPITAL

Phạm Cẩm Phương1,, Nguyễn Đức Luân1, Nguyễn Thuận Lợi1, Nguyễn Quang Hùng1, Nguyễn Hữu Bảng2, Đậu Quang Liêu3, Hoàng Thùy Nga3, Nguyễn Thị Chi3, Võ Thị Huyền Trang1, Nguyễn Thị Hoa Mai1, Ngô Thị Phương Nhung2, et al.1,2,3
1 Nuclear Medicine and Oncology Center, Bach Mai Hospital
2 Department of Infectious Diseases, Bach Mai Hospital
3 Hanoi Medical University Hospital

Main Article Content

Abstract

Aim: commenting on the concentration of AFP, AFP-L3, PIVKA II and characteristics of abdominal ultrasound in hepatitis B patients at Bach Mai hospital. Patients and methods: Prospective study of 311 hepatitis B patients from October 2019 to March 2021. Results: The most common age group was 41-70 years old (68, 5%). The average age was 48.7±12.3 years old, the disease was more common in men than women (2.5 times). The most common clinical symptoms include: Anorexia (25.7%), fatigue (32.5%), right lower quadrant abdominal pain (16.7%), abdominal distension (16.7%), jaundice (17.4%). 77.5% of patients did not have cirrhosis, and 22.5% of patients had cirrhosis. 2,3% of patients had both hepatitis B and C. Median of AFP, AFP-L3, PIVKA in the elevated group are 17.2 ng/mL; 9.4%; 24.0 mAU/mL, respectively. 23 patients had liver tumors (7.4%) of which 78.3% of tumors are less than 3 cm. All tumor lesions are benign. Conclusion: AFP, AFP-L3, PIVKA levels can be increased in hepatitis B with/without cirrhosis but not high. In this group, we should follow up regularly to detect liver cancer.

Article Details

References

1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. doi: 10.3322/caac.21660. Epub 2021 Feb 4. PMID: 33538338.
2. Trần Bảo Nghi (2016). Nghiên cứu xơ hóa gan ở bệnh nhân bệnh gan mạn bằng đo đàn hồi gan thoáng qua đối chiếu với mô bệnh học. Luận án tiến sỹ y học, Đại học Y dược Huế.
3. Gabriele Ricco, Chiara Cosma, Giorgio Bedogni et al (2020), Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma. Cancer Biomark, 2020 29(2):189-196.
4. Robert J Wong, Aijaz Ahmed , Robert G Gish (2015), Elevated alpha-fetoprotein: differential diagnosis - hepatocellular carcinoma and other disorders, Clin Liver Dis, 2015, May;19(2):309-23.
5. S. Berhane, H. Toyoda, T. Tada et al (2016). Role of the GALAD and BALAD-2 Serologic Models in Diagnosis of Hepatocellular Carcinoma and Prediction of Survival in Patients. Clin Gastroenterol Hepatol, 14 (6), 875-886.e876.
6. Chih-Wei Yen , Yuan-Hung Kuo , Jing-Houng Wang et al (2018), Did AFP-L3 save ultrasonography in community screening? Kaohsiung J Med Sci, 2018 Oct;34(10):583-587.